Drug resistance guide being pondered by CDC. As HIV drug resistance rises, surveillance needed.
Guidelines released by two groups this year recommend resistance testing for all recently infected patients beginning treatment. However, both groups also suggest considering resistance testing for drug-naive patients whose infections are not recent, particularly if the prevalence of resistance in the patient's area is 5% or greater.
D019380:Anti-HIV Agents / Q000494:pharmacology*; D002487:Centers for Disease Control and Prevention, U.S.; D024882:Drug Resistance, Viral; D005838:Genotype; D017408:Guidelines as Topic; D006678:HIV / Q000187:drug effects / Q000235:genetics; D015658:HIV Infections / Q000821:virology*; D006801:Humans; D011159:Population Surveillance; D014481:United States
D019380:Anti-HIV Agents